title: Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.
authors.forename: I
authors.initials: I
authors.lastname: Cohen
authors.forename: D J
authors.initials: DJ
authors.lastname: Rosen
authors.forename: M
authors.initials: M
authors.lastname: Altaras
authors.forename: Y
authors.initials: Y
authors.lastname: Beyth
authors.forename: J
authors.initials: J
authors.lastname: Shapira
authors.forename: D
authors.initials: D
authors.lastname: Yigael
mesh_terms: D001943:Breast Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D010048:Ovarian Cysts / Q000139:chemically induced* / Q000473:pathology; D010053:Ovary / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology; D017697:Premenopause; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014463:Ultrasonography; D014591:Uterine Diseases / Q000139:chemically induced* / Q000473:pathology; D014599:Uterus / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology
chemical_list: D013629:Tamoxifen